Cash reserves of $5.2 million, no debt, and going to pull in $19M in sales for this half year for the pollucite.Surely PIO has to be presently undervalued?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%